Advanced Search

 

Study ID Status Title Patient Level Data
25000/446 Completed Comparison of Amoxicillin Concentrations in Plasma and Middle Ear Fluid Following Administration of Augmentin 45/3.2 mg/kg to Pediatric Patients with Acute Otitis Media.
25000/447 Completed A Comparison of the Safety and Efficacy of q 12 hrs Augmentin-90/6.4 mg/kg/day and q 12 hrs Augmentin-45/6.4 mg/kg/day in the Treatment of Acute Otitis Media in Children: A Randomized Double-Blind, Multicenter, Comparative Study.
25000/536 Completed An Open-Label Study to Demonstrate Bacteriological Efficacy of Augmentin ES in the Treatment of Acute Otitis Media Due to S. pneumoniae.
25000/541 Completed The Effect of Antimicrobial Therapy for Otitis Media on Pneumococcal Carriage and Antibiotic Resistance Study Listed on ClinicalStudyDataRequest.com
25000/542 Completed A pharmacokinetic study of diffusion of Augmentin in middle ear in a population of children with chronic serous otitis media requiring transtympanic drains. Three day course of Augmentin (80 mg/kg/j three times a day, formula 100mg/ml) prior to the planned surgery.
25000/546 Completed A Randomised, Double-Blind, Double-Dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily Versus Oral Augmentin 875/125mg Twice Daily for 7 Days in the Treatment of Adults with Bacterial Community Acquired Pneumonia
25000/547 Completed An Open, Non-Comparative Multicenter Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125 mg Twice Daily for 7 days for the Treatment of Bacterial Community-Acquired Pneumonia in adults. Study Listed on ClinicalStudyDataRequest.com
25000/548 Completed A Randomized, double-blind, double-dummy, multicenter, parallel group study to assess the efficacy and safety of oral Augmentin SR 2000/125mg twice daily for 7 days versus oral clarithromycin 500mg twice daily for 7 days in the treatment of acute exacerbation of chronic bronchitis.
25000/549 Completed A Randomised, Double-blind, Double-dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily for 7 days versus Oral Levofloxacin 500mg Once a Day for 7 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis.
25000/550 Completed A Randomised, Double-Blind, Double-Dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR, Two Tablets Equal to 2000/125mg, Twice Daily for 10 Days Versus Levofloxacin (Levaquin) 500mg Once Daily for 10 Days in the Treatment of Adults with Acute Bacterial ...
25000/551 Completed An Open, Non-Comparative Multicenter Study to Assess the Efficacy and Safety of Oral AUGMENTIN SR 2000/125mg Twice Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.
25000/552 Completed A two-part crossover study to assess the pharmacokinetics of amoxicillin after administration with clavulanate of pharmacokinetically enhanced formulations of amoxicillin in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
25000/553 Completed An open, randomised, balanced, three period, single dose crossover study to investigate the effect of food on the bioavailability of pharmacokinetically enhanced (PE) oral Augmentin® in healthy male and female volunteers. Study Listed on ClinicalStudyDataRequest.com
25000/555 Completed Evaluating the Impact of Amoxicillin/Clavulanate Potassium Therapy on Carriage of Susceptible and Resistant Streptococcus pneumoniae. Study Listed on ClinicalStudyDataRequest.com
25000/556 Completed A randomised, double-blind, double-dummy, multicentre, parallel group study to assess the efficacy and safety of oral amoxicillin/clavulanate (Augmentin SR) 2000/125mg twice daily for 10 days versus oral amoxicillin/clavulanate 1000/125mg three times daily for 10 days for the treatment of bacter ...
25000/557 Completed A Randomised, Double-Blind, Double-Dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily Versus Oral Augmentin 875/125mg Three Times Daily for 7 or 10 Days for the Treatment of Bacterial Community Acquired Pneumonia in Adults. Study Listed on ClinicalStudyDataRequest.com
25000/558 Completed An open, randomised, four-part crossover study to investigate the relative bioavailability of three new pharmacokinetically enhanced (PE) formulations of Augmentin in comparison to the standard immediate release (IR) formulation of Augmentin in healthy volunteers.
25000/559 Completed Efficacy and tolerability of amoxicillin/clavulanate versus cefaclor for a period of 10 days in the treatment of recurrent acute otitis media in children.
25000/563 Completed A single-blind, randomized, multicentre, parallel group study to compare the efficacy and safety of Augmentin 500/125mg by mouth twice daily versus Cefaclor 250mg by mouth three times a day versus Cefuroxime 250mg by mouth twice daily in the treatment of acute exacerbations of chronic bronchitis in Chinese adult patients.
25000/574 Completed A study to determine the pharmacokinetic profiles of amoxicillin and clavulanate over a 12 hour dosing interval in paediatric patients in the weight range of 5 to 40 kg receiving Augmentin at 45/3.2 mg/kg orally every 12 hours for up to 10 days.
25000/575 Completed A randomised, controlled and parallel phase I study to evaluate the selection of resistance to penicillin and erythromycin in the nasopharyngeal flora of adult healthy volunteers after a standard oral 7-day treatment of amoxicillin/clavulanic acid or clarithromycin or a 3-day treatment with azithromycin.
25000/583 Completed An open, randomised, three way crossover study to investigate the effect of Maalox on the bioavailability of pharmacokinetically enhanced oral Augmentin (BRL 25000) in healthy male and female volunteers.
25000/590 Completed Ways of use in ENT practice of a new Augmentin formulation 1g/125mg (1 intake = 2 tablets 500mg/62.5mg) in treatment of acute sinusitis in adults.
25000/591 Completed A double-blind, placebo-controlled, randomised, phase III clinical trial to compare the efficacy of oral Augmentin SR 2000/125 to placebo given as a single dose as prophylaxis or twice daily over 5 days as treatment to reduce the infective and inflammatory complications after undergoing maxillofacial surgery for third mandibular molar removal.
25000/592 Completed An Open, Non-Comparative Multicenter Study to Assess the Efficacy and Safety of Oral AUGMENTIN SR 2000/125mg Twice Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.